ArticleSocial psychiatry and psychiatric epidemiology2026
Socioeconomic status modifies the association between adherence to the Mediterranean diet and cognitive outcomes: results from the Collaborative PROMED-COG Pooled Cohorts Study.
Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From plate to brain: role of mediators and moderators on the impact of diet on Alzheimer's disease.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study examines whether adherence to the Mediterranean diet (MD), alone and combined with physical activity (MedEx), is associated with cognitive decline and dementia incidence, with socioeconomic status (SES) as a potential modifier.
methodsWe included 8,568 subjects (mean age 72.3 ± 9.6 years, 52.4% female) from three pooled Italian population-based studies. MD adherence was assessed using the Panagiotakos algorithm. We analyzed the association of MD and MedEx adherence, both continuously and categorized in tertiles, with cognitive decline and incident dementia using Cox regression. SES modification was examined through interaction analysis and SES-stratified models.
resultsCognitive decline occurred in 38.1% of participants but was not associated with MD adherence. In SES-stratified analysis, among high SES individuals, each 2-point increase in MD adherence reduced cognitive decline risk by 14%, and high MD adherence was associated with a 48% reduction (HR 0.52, 95%CI 0.31-0.90). In this group, medium MedEx adherence reduced cognitive decline risk by 77% (HR 0.23, 95%CI 0.07-0.83). No significant association was found between MD/MedEx adherence and incident dementia (4.2%), regardless of SES. DISCUSSION: SES may modify the relationship between MD and cognitive decline, with greater benefits observed in higher SES groups. Further studies, particularly in vulnerable populations, are needed to inform tailored preventive strategies for cognitive decline.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.